TLR3对NF-κB信号通路的调控在肿瘤中的意义

doi:10.11904/j.issn.1002-3070.2015.06.013

Abstract

Abstract: NF-κBs is a member of Rel protein family of transcription factors,which is expressed in all cells and is involved in important physiological and pathological regulatory mechanisms,including the regulation of TLR3 on NF-κB signaling pathway,which has been attracted widespread attention.This paper reviews the molecular mechanisms of the regulation.We summarizes the role of host immune responses in tumor development,which is mediated by the related signal molecules.It reveals that some key proteins in the regulation have a great significance to the treatment of diseases,as used as the therapeutic targets,and is conducive to the understanding of function and diversity in tumor tissue.

Key words: TLR3, NF-κB, TRIF, Signal transduction, Tumor

CLC Number:

R392.3

ZHOU Hong, CHEN Li. The regulation of TLR3 on NF-κB signaling pathway and its significance in the pathogenesis of tumor[J]. PRACTICAL ONCOLOGY JOURNAL, 2015, 29(6): 540-544.

References

1 Napetschnig J,Wu H.Molecular basis of NF-κB signaling[J].Annu Rev Biophys,2013,42(3):443-468.
2 Liu H,Li J,Tillman B,et al.TLR3/4 signaling is mediated via the NF κB-CXCR4/7 pathway in human alcoholic hepatitis and non-alcoholic steatohepatitis which formed Mallory-Denk bodies[J].Exp Mol Pathol,2014,97(2):234-240.
3 Abu-Amer Y.NF-κB signaling and bone resorption[J].Osteoporos Int,2013,24(9):2377-2386.
4 Hayden MS,Ghosh S.NF-κB,the first quarter-century:remarkable progress and outstanding questions[J].Genes Dev,2012,26(3):203-234.
5 Yang L,Seki E.Toll-like receptors in liver fibrosis:cellular crosstalk and mechanisms[J].Front Physiol,2012,22(3):138-155.
6 Huang Q,Pope RM.Toll-like receptor signaling:a potential link among rheumatoid arthritis,systemic lupus,and atherosclerosis[J].J Leukoc Biol,2010,88(2):253-262.
7 Hosoya S,Villena J,Shimazu T,et al.Immunobiotic lactic acid bacteria beneficially regulate immune response triggered by poly(I:C)in porcine intestinal epithelial cells[J].Vet Res,2011,42(6):111-119.
8 Zheng C,Yin Q,Wu H.Structural studies of NF-κB signaling[J].Cell Res,2011,21(1):183-195.
9 Yamashita M,Chattopadhyay S,Fensterl V,et al.Epidermal growth factor receptor is essential for Toll-like receptor 3 signaling[J].Sci Signal,2012,5(233):50-61.
10 Mandal P,Berger SB,Pillay S,et al.RIP3 induces apoptosis independent of pronecrotic kinase activity[J].Mol Cell,2014,56(4):484-495.
11 Kaiser WJ,Sridharan H,Huang C,et al.Toll-like receptor 3-mediated necrosis via TRIF,RIP3,and MLKL[J].J Biol Chem,2013,288(43):31268-31279.
12 Yoneda K,Sugimoto K,Shiraki K,et al.Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma:differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis[J].Int J Oncol,2008,33(5):929-936.
13 Eiró N,Altadill A,Juárez LM,et al.Toll-like receptors 3,4 and 9 in hepatocellular carcinoma:Relationship with clinicopathological characteristics and prognosis[J].Hepatol Res,2014,44(7):769-778.
14 Guo Z,Chen L,Zhu Y,et al.Double-stranded RNA-induced TLR3 activation inhibits angiogenesis and triggers apoptosis of human hepatocellular carcinoma cells[J].Oncol Rep,2012,27(2):396-402.
15 Xu YY,Chen L,Zhou JM,et al.Inhibitory effect of dsRNA TLR3 agonist in a rat hepatocellular carcinoma model[J].Mol Med Rep,2013,8(4):1037-1042.
16 Chen L,Xu YY,Zhou JM,et al.TLR3 dsRNA agonist inhibits growth and invasion of HepG2.2.15 HCC cells[J].Oncol Rep,2012,28(1):200-206.
17 Xu YY,Chen L,Wang GL,et al.A synthetic dsRNA,as a TLR3 pathwaysynergist,combined with sorafenib suppresses HCC in vitro and in vivo[J].BMC Cancer,2013,13:527.
18 Li TT,Ogino S,Qian ZR.Toll-like receptor signaling in colorectal cancer:carcinogenesis to cancer therapy[J].World J Gastroenterol,2014,20(47):17699-17708.
19 Nojiri K,Sugimoto K,Shiraki K,et al.The expression and function of Toll-like receptors 3 and 9 in human colon carcinoma[J].Oncol Rep,2013,29(5):1737-1743.
20 Lin CJ,Grandis JR,Carey TE,et al.Head and neck squamous cell carcinoma cell lines:established models and rationale for selection[J].Head Neck,2007,29(2):163-188.
21 Argiris A,Karamouzis MV,Raben D,et al.Head and neck cancer[J].Lancet,2008,371(9625):1695-1709.
22 Szczepanski MJ,Czystowska M,Szajnik M,et al.Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack[J].Cancer Res,2009,69(7):3105-3113.
23 Jackson-Bernitsas DG,Ichikawa H,Takada Y,et al.Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma[J].Oncogene,2007,26(10):1385-1397.
24 Umemura N,Zhu J,Mburu YK,et al.Defective NF-κB signaling in metastatic head and neck cancer cells leads to enhanced apoptosis by dsRNA[J].Cancer Res,2012,72(1):45-55.
25 Meyer C,Pries R,Wollenberg B.Established and novel NF-κB inhibitors lead to downregulation of TLR3 and the proliferation and cytokine secretion in HNSCC[J].Oral Oncol,2011,47(9):818-826.
26 Yu M,Levine SJ.Toll-like Receptor 3,RIG-I-like Receptors and the NLRP3 Inflammasome:Key Modulators of Innate Immune Responses to Double-stranded RNA Viruses[J].Cytokine Growth Factor Rev,2011,22(2):63-72.
27 Chiron D,Pellat-Deceunync C,Amiot M,et al.TLR3 ligand induces NF-κB activation and various fates of multiple myeloma cells depending on IFN-α production[J].J Immunol,2009,182(7):4471-4478.
28 Jia D,Yang W,Li L,et al.β-Catenin and NF-κB co-activation triggered by TLR3 stimulation facilitates stem cell-like phenotypes in breast cancer[J].Cell Death Differ,2015,22(2):298-310.
29 Zhan Z,Xie X,Cao H,et al.Autophagy facilitates TLR4-and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination[J].Autophagy,2014,10(2):257-268.
30 Palchetti S,Starace D,De Cesaris P,et al.Transfected poly(I:C)activates different dsRNA receptors leading to apoptosis or immunoadjuvant response in androgen-independent prostate cancer cells[J].J Biol Chem,2015,290(9):5470-5483.
31 Salaun B,Coste I,Rissoan MC,et al.TLR3 can directly trigger apoptosis in human cancer cells[J].J Immunol,2006,176(8):4894-4901.
32 Estornes Y,Toscano F,Virard F,et al.dsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8[J].Cell Death Differ,2012,19(9):1482-1494.

[1]	ZHANG Maoxiang,SUN Huixin,SONG Bingbing. Analysis of the incidence and mortality of malignant tumors in Daoli District,Harbin,2008—2012 [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 261-265.
[2]	LIU Yishu,QU Guofan. Progress in long-chain non-coding RNA in osteosarcoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 266-270.
[3]	HOU Yuxue,LI Xiaoli. The research progress of Wnt7a and malignant tumors,and its relationship [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 271-275.
[4]	XU Hui, LI Xi, ZHOU Chunshui. Screening of lung cancer tumor-associated suppressor genes using shRNA library targeting human transcriptome [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 97-102.
[5]	YUAN Guixia, LI Yan, FENG Wanqi, XIA Xiaojuan, LI Xu. Mechanism of tumor suppressor gene DKK2 inhibiting proliferation of nephroblastoma cells in children [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 14-20.
[6]	DING Jiexian, ZHANG Jin, CHEN Yonggang, WANG Xingwen, WANG Shuanke. Progress in Wnt signaling pathway and tumorigenesis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 73-77.
[7]	KAN Jun, ZHOU Daihan, ZHANG Enxin. Research progress in tumor with cardiovascular disease [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 558-561.
[8]	LIU Juan, ZHANG Shutian. Advances in research on the mechanism of cyclin-dependent kinase inhibitor 3(CDKN3)in tumors [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 575-578.
[9]	CHEN Lin, WANG Enxiang, LIU Qunyou, ZHONG Ying, ZHOU Guoliang, ZHAO Xiyan. CDX2 gene inhibits of colon cancer cell proliferation by NF-κB signaling pathway [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 398-403.
[10]	LI Yue, XU Ke, HAN Zengxiang, SUN Min, FAN Guohua, ZHANG Yong. Advances in the role of tumor-associated macrophage in colon cancer and targeted therapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 450-454.
[11]	WANG Yuan, SUN Yihua. Advance in the role of β-catenin in soft tissue tumors [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 455-459.
[12]	ZHANG Yali, SU Danke. Research progress in gadolinium-based molecular probes for tumor targeting imaging [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 460-463.
[13]	HAN Bangling, WANG Yimin, XUE Yingwei. Research progress of vitamin D in tumors of digestive system [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 471-475.
[14]	HAN Bangling,WANG Yimin,XUE Yingwei. Research progress in the relationship between neutrophils and malignant tumors [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 349-352.
[15]	ZHANG Yiyun,WU Huaxing. Progress of metabolic plasticity in tumor growth and metastasis [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 362-366.

The regulation of TLR3 on NF-κB signaling pathway and its significance in the pathogenesis of tumor

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments